RxDoctor Payments Data

Olivia Eckstein, PA

Medical · Batesville, INNPI 1902357759

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,378 of the $6,000 with a category attached, or 89.6%. It is spread thinly across 22 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations.

$6,000in general payments, 2019–2025

Across 359 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$1K
  • Johnson & Johnson$1K
  • Sun Pharmaceutical Industries Inc.$622
  • E.r. Squibb & Sons, L.L.C.$492
  • Amgen$246
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$5,37890%
  • Education$62210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,000 in reported general payments places this provider in the 85th percentile of 273 medical providers in Indiana.

See all medical providers in Indiana

Medicare billing

Part B allowed, 2024
$227,084
Medicare patients
1,170
Services billed
4,748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa14$298,541
Dupixent PenDupilumab19$77,576
Humira(Cf) PenAdalimumab11$69,909
Clobetasol Propionate195$8,255
Fluorouracil93$7,402
Acitretin12$3,138
Calcipotriene27$3,054
Metronidazole44$2,068
Tacrolimus16$1,629
Ketoconazole134$1,563
Triamcinolone Acetonide128$1,192
Ciclopirox43$1,091
Doxycycline Hyclate60$1,059
Tretinoin23$1,003
Fluocinonide18$920

Paid to pharmacies, not to this prescriber.

Other medical in Batesville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →